Terms: = Pancreatic cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Treatment
5104 results:
1. A Humanized Patient-Derived Xenograft Model for pancreatic cancer.
Lundy J
Methods Mol Biol; 2024; 2806():91-100. PubMed ID: 38676798
[TBL] [Abstract] [Full Text] [Related]
2. Senolysis of gemcitabine-induced senescent human pancreatic cancer cells.
Hoque MM; Iida Y; Kotani H; Harada M
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2075. PubMed ID: 38662379
[TBL] [Abstract] [Full Text] [Related]
3. A pancreatic cancer organoid-in-matrix platform shows distinct sensitivities to T cell killing.
Lahusen A; Cai J; Schirmbeck R; Wellstein A; Kleger A; Seufferlein T; Eiseler T; Lin YN
Sci Rep; 2024 Apr; 14(1):9377. PubMed ID: 38654067
[TBL] [Abstract] [Full Text] [Related]
4. Nuclear MAST4 Suppresses FOXO3 through Interaction with AKT3 and Induces Chemoresistance in pancreatic Ductal Carcinoma.
Fujiwara-Tani R; Sasaki T; Bhawal UK; Mori S; Ogata R; Sasaki R; Ikemoto A; Kishi S; Fujii K; Ohmori H; Sho M; Kuniyasu H
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612866
[TBL] [Abstract] [Full Text] [Related]
5. Armored TGFβRIIDN ROR1-CAR T cells reject solid tumors and resist suppression by constitutively-expressed and treatment-induced TGFβ1.
Tran TM; Chand Thakuri BK; Nurmukhambetova S; Lee JJ; Hu P; Tran NQ; Steimle B; Dash P; Schneider D
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38609317
[TBL] [Abstract] [Full Text] [Related]
6. Genetic Signature of Human pancreatic cancer and Personalized Targeting.
Reshkin SJ; Cardone RA; Koltai T
Cells; 2024 Mar; 13(7):. PubMed ID: 38607041
[TBL] [Abstract] [Full Text] [Related]
7. Induction of islet autoimmunity to defective ribosomal product of the insulin gene as neoantigen after anti-cancer immunotherapy leading to autoimmune diabetes.
van Tienhoven R; Jansen DTSL; Park M; Williams JC; Larkin J; Quezada SA; Roep BO
Front Immunol; 2024; 15():1384406. PubMed ID: 38596681
[TBL] [Abstract] [Full Text] [Related]
8. PRaG 3.0 therapy for human epidermal growth factor receptor 2-positive metastatic pancreatic ductal adenocarcinoma: A case report.
Kong YH; Xu ML; Zhang JJ; Chen GQ; Hong ZH; Zhang H; Dai XX; Ma YF; Zhao XR; Zhang CY; Chen RZ; Xing PF; Zhang LY
World J Gastroenterol; 2024 Mar; 30(9):1237-1249. PubMed ID: 38577174
[TBL] [Abstract] [Full Text] [Related]
9. Protein neddylation and its role in health and diseases.
Zhang S; Yu Q; Li Z; Zhao Y; Sun Y
Signal Transduct Target Ther; 2024 Apr; 9(1):85. PubMed ID: 38575611
[TBL] [Abstract] [Full Text] [Related]
10. Cyclophilin D knockout significantly prevents HCC development in a streptozotocin-induced mouse model of diabetes-linked NASH.
Stauffer WT; Bobardt M; Ure DR; Foster RT; Gallay P
PLoS One; 2024; 19(4):e0301711. PubMed ID: 38573968
[TBL] [Abstract] [Full Text] [Related]
11. Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia.
Spadafora V; Pryce BR; Oles A; Talbert EE; Romeo M; Vaena S; Berto S; Ostrowski MC; Wang DJ; Guttridge DC
BMC Cancer; 2024 Apr; 24(1):414. PubMed ID: 38570770
[TBL] [Abstract] [Full Text] [Related]
12. Inoculation of Pan02 cells produces tumor nodules in mouse pancreas: Characterization of a novel orthotopic pancreatic ductal adenocarcinoma tumor model for interventional studies.
Griffin JI; Chen X; Duan L; Mu Q; Ho RJY
PLoS One; 2024; 19(3):e0300723. PubMed ID: 38547077
[TBL] [Abstract] [Full Text] [Related]
13. Gemcitabine Modulates HLA-I Regulation to Improve Tumor Antigen Presentation by pancreatic cancer Cells.
Larson AC; Knoche SM; Brumfield GL; Doty KR; Gephart BD; Moore-Saufley PR; Solheim JC
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542184
[TBL] [Abstract] [Full Text] [Related]
14. Tetrastigma hemsleyanum (Sanyeqing) root extracts evoke S phase arrest while inhibiting the migration and invasion of human pancreatic cancer PANC-1 cells.
Sun Y; Qin H; Zhang C; Xu J; Zhang T
BMC Complement Med Ther; 2024 Mar; 24(1):133. PubMed ID: 38539165
[TBL] [Abstract] [Full Text] [Related]
15. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
[TBL] [Abstract] [Full Text] [Related]
16. Human-derived bacterial strains mitigate colitis via modulating gut microbiota and repairing intestinal barrier function in mice.
Dai J; Jiang M; Wang X; Lang T; Wan L; Wang J
BMC Microbiol; 2024 Mar; 24(1):96. PubMed ID: 38521930
[TBL] [Abstract] [Full Text] [Related]
17. Nanodrug-bacteria conjugates-mediated oncogenic collagen depletion enhances immune checkpoint blockade therapy against pancreatic cancer.
Li Z; Mo F; Guo K; Ren S; Wang Y; Chen Y; Schwartz PB; Richmond N; Liu F; Ronnekleiv-Kelly SM; Hu Q
Med; 2024 Apr; 5(4):348-367.e7. PubMed ID: 38521069
[TBL] [Abstract] [Full Text] [Related]
18. Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancer.
Brown NF; Murray ER; Cutmore LC; Howard P; Masterson L; Zammarchi F; Hartley JA; van Berkel PH; Marshall JF
Pancreatology; 2024 May; 24(3):445-455. PubMed ID: 38519394
[TBL] [Abstract] [Full Text] [Related]
19. Tumor suppression effect of ultrasound-sensitive nanoparticles with focused ultrasound in a pancreas cancer xenograft model.
Kim S; Lee JY; Park EJ; Ahn YD; Cheon Y; Sim W; Lee HJ
Eur Radiol Exp; 2024 Mar; 8(1):39. PubMed ID: 38503996
[TBL] [Abstract] [Full Text] [Related]
20. Combining bulk and scRNA-seq to explore the molecular mechanisms governing the distinct efferocytosis activities of a macrophage subpopulation in PDAC.
Zhu S; Cheng Q; Zou M; Li C; Tang Y; Xia L; Jiang Y; Gong Z; Tang Z; Tang Y; Luo H; Peng N; Wang X; Dong X
J Cell Mol Med; 2024 Apr; 28(7):e18266. PubMed ID: 38501838
[TBL] [Abstract] [Full Text] [Related]
[Next]
